EndovaScular Versus mediCaL mAnagement of Uncomplicated Type B Intramural heMatoma Trial (ESCLAIM)
Randomized Comparison of Strategies for Uncomplicated Type B Aortic Intramural Hematoma: EndovaScular Versus mediCaL mAnagement of Type B Intramural heMatoma Trial
Sponsor: First Affiliated Hospital of Xinjiang Medical University
This NA trial investigates Intramural Hematoma and is currently ongoing. First Affiliated Hospital of Xinjiang Medical University leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Apr 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Apr 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Apr 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Sep 2021 — Apr 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jun 2021 — Sep 2021 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Apr 2021 — Jun 2021 [monthly]
Active Not Recruiting NA
First recorded
Mar 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital of Xinjiang Medical University
- Guangdong Provincial People's Hospital
- Hanyang University
- Henan Provincial Chest Hospital
- Jiangmen Central Hospital
- Jieyang People's Hospital
- Shenzhen People's Hospital
- The First Affiliated Hospital of Guangzhou Medical University
- Xinqiao Hospital of Chongqing
For direct contact, visit the study record on ClinicalTrials.gov .